Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany

Annals of Hematology

Volumn 72, Issue 1, 1996, Pages 35-39

  Riggert, J ^a   Schwartz, D W M ^b   Uy, A ^a   Simson, G ^a   Jelinek, F ^b   Fabritz, H ^a   Mayr, W R ^b   Kohler M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Blood transfusion; HCV; Incidence; PCR; Prevalence; RIBA; Risk

Indexed keywords

ARTICLE; AUSTRIA; BLOOD COMPONENT; BLOOD DONOR; GERMANY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INCIDENCE; INFECTION RISK; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0030068282     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00663014     Document Type: Article

References (32)

1. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ (1991) Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 325:1325-1329
2. Allander T, Gruber A, Naghavi M, Beyene A, Söderström T, Björkholm M, Grillner L, Persson MAA (1995) Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345:603-607
3. Alter HJ (1995) To C or not to C: these are the questions. Blood 85:1681-1695
4. Alter HJ, Purcell RH, Shin JW, Melpolder JC, Houghton M, Choo QL, Kuo G (1989) Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321:1494-1500
5. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ, for the Sentinel Counties Chronic non-A, non-B Hepatitis Study Team (1992) The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899-1905
6. Baele PL, De Bruyere M, Deneys V, Dupont E, Flament J, Lambermont M, Latinne D, Steensens L, van Camp B, Waterloos H (1994) Bedside transfusion errors. A survey by the Belgium SANGUIS group. Vox Sang 66:117-121
7. Barrera JM, Francis B, Ercilla G, Nelles M, Achord D, Darner J, Lee SR (1995) Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang 68:15-18
8. Blajchman MA, Bull SB, Feinman SV, for the Canadian Post-Transfusion Hepatitis Prevention Study Group (1995) Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Lancet 345:21-25
9. Bresters D, Cuypers HT, Reesink HW, Shasberg WP, van der Poel CL, Mauser-Bunschoten EP, Houghton M, Choo QL, Kuo G, Lesniewski R (1992) Enhanced sensitivity of a second-generation ELISA for antibody to hepatitis C virus. Vox Sang 62:213-217
10. Clemens JM. Taskar S, Chau K, Vallari D, Shih JWK, Alter HJ, Schleicher JB, Mimms LT (1992) IgM antibody response in acute hepatitis C viral infection. Blood 79:169-172
11. Courouce AM, Barin F, Botte C, Lunel F, Maisonneuve P, Maniez M, Trepo C (1995) A comparative evaluation of seven anti-hepatitis C virus screening tests. Vox Sang 69:213-216
12. Da Silva Cardoso M, Koerner K, Epple S, Kubanek B (1993) Prevalence of HCV-RNA-positive blood donors and correlation to ELISA and RIBA status. Ann Haematol 66:147-151
13. Dodd RY, Reesink HW, Busch MP, Petersen LR, Lackritz EM, Blajchman MA, Barbara JAJ, Kuehnl P, Knoedler B, Schönitzer D, Högman CF, Lindholm A, Sekiguchi S, Wendel S (1995) International Forum. Do surrogate tests improve the safety of the blood supply? Vox Sang 69:280-291
14. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, Reitz BA, Nelson KE (1992) The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327:369-373
15. Esteban JI, Gonzalez A, Hernandez JM, Viladomiu L, Sanchez C, Lopez-Talavera JC, Lucea D, Martin-Vega C, Vidal X, Esteban R, Guardia J (1990) Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323:1107-1112
16. Esteban JI, Lopez-Talavera JC, Genasca J, Gonzalez A, Vargas V, Buti M, Guardia J, Esteban R (1992) Evaluation of anti-HCV positive blood donors identified during routine screening. Arch Virol 4 [Suppl]: 244-246
17. Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Crepaldi M, Pagano A, Locatelli F (1994) Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective study. Nephrol Dial Transplant 9:1611-1615
18. Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Trute A, Parker D, Barbara JAJ, Contreras M, Aloysius S (1990) Detection of hepatitis viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet 335:1419-1422
19. Geherding JL (1994) Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 170:1410-1417
20. Koerner K, da Silva Kardosos M, Dengler T, Kerowgan M, Kubanek B (1995) Look back on hepatitis C-virus infections of HCV-RIBA-2-positive blood donors and their respective recipients (letter). Vox Sang 69:78-79
21. Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M, Choo QL, Kuo G (1990) Detection of antibody against antigen expressed by molecularly cloned hepatitis virus cDNA: application to diagnosis and blood screening for post-transfusion hepatitis. Proc Natl Acad Sci U S A 87:983-987
22. Nelson KE, Donahue JG, Stambolis V (1992) Post-transfusion hepatitis C virus infection (letter). N Engl J Med 327:1601-1602
23. Nubling CM, Willkommen H, Löwer J (1995) Hepatitis C transmission associated with intravenous immunoglobulins (letter). Lancet 345:1174
24. Schwartz DWM, Simson G, Baumgarten K, Fabritz H, Riggert J, Neumeyer H, Mayr WR, Köhler M (1995) Risk of human immunodeficiency virus (HIV) transmission by anti-HIV-negative blood components in Germany and Austria. Ann Haematol 70:209-213
25. Seeff LB, Buskell-Bales Z, Wriaht EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, Gitnick G, Knodell RG, Perillo RP, Stevens CE, Hollingsworth CE, and the National Heart, Lung, and Blood Institute Study Group (1992) Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327:1906-1911
26. Shimizu YK, Weiner AJ, Rosenblatt J, Wong DC, Shapiro M, Popkin T, Houghton M, Alter HJ, Purcell RH (1990) Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci U S A 87:6441-6444
27. Silva AE, Hosein B, Boyle RW, Fang CT, Shindo M, Waggoner JE, Hoofnagle JA, DiBisceglie AM (1994) Diagnosis of chronic hepatitis C: comparison of immunoassays and the polymerase chain reaction. Am J Gastroenterol 89:493-496
28. Tong MJ, El-Farra NS, Reikes AR, Co RL (1995) Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463-1466
29. Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C (1994) Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 66:122-129
30. Vallari DS, Jett BW, Alter HJ, Mimms LT, Holzman R, Shih JWK (1992) Serological markers of post-transfusion hepatitis C virus infection. J Clin Microbiol 30:552-556
31. Vrielink H, van der Poel CL, Reesink HW, Zaijer HL, Scholten E, Kremer LCM, Cuypers HTM, Lelie PN, van Oers MHJ (1995) Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet 345:95-96
32. Vrielink H, van der Poel CL, Reesink HW, Zaijer HL, Lelie PN (1995) Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Vox Sang 68:55-56